Search Results - "Van Moorter, L"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    PO-0750 MATURE RESULTS OF A PHASE 2 DOSE-ESCALATION STUDY IN UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER

    PO-0750 MATURE RESULTS OF A PHASE 2 DOSE-ESCALATION STUDY IN UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER by Collen, C, Schallier, D, Meysman, M, Van Moorter, L, Bral, S, Everaert, H, Verdries, D, De Ridder, M

    Published in Radiotherapy and oncology (01-05-2012)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation in patients with unresectable stage III non-small-cell lung cancer (NSCLC): FEV1 as prognostic marker

    Multicenter phase II trial of carboplatin (Cb) and gemcitabine (G) followed by concurrent chemoradiation in patients with unresectable stage III non-small-cell lung cancer (NSCLC): FEV1 as prognostic marker by Germonpré, P. R., Janssens, A., Van Moorter, L., Verresen, D., Galdermans, D., Devogelaere, R., Ottevaere, H., Mentens, Y., De Pooter, C., Goor, C.

    Published in Journal of clinical oncology (20-05-2008)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: